“Unfortunately, the entire evidence base has been perverted,” said Joseph Ross, a professor at Yale Medical School who has studied the issue.  

Read More
zyrem.jpg

"I’m as big a fan of the 1st Amendment as anyone, but this decision strikes me as fundamentally flawed.  We’re not talking about a right to express yourself. We’re talking about selling stuff — stuff that could harm or even kill you if used improperly."  David Lazarus, LA Times

Read More
just_say_no.jpg

Physicians at Sloan Kettering Cancer Center have taken a giant step toward stemming the tide of unconscionable pharmaceutical industry price gouging.  Sloan-Kettering physicians said NO to Sanofi’s new anti-cancer drug, Zaltrap which the company priced at $11,063 per month. Drs. Peter B. Bach, Leonard B. Saltz, and Robert E Wittes publicized the center’s position, urging…

Read More

The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling.  It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars.

Read More

“Overuse is one of the most serious crises in American medicine.” The crisis is not only of misspending of resources, overuse of medical treatments is causing  treatment-produced harm, including preventable deaths. 

Read More

An audit by Daniel Levinson, Inspector General of DHHS, confirms what has already been documented: that antipsychotics are widely misprescribed for unapproved uses and  taxpayers are saddled with the high cost  through Medicaid and Medicare.

Read More